Centaur Pharmaceuticals was founded in 1978 and today is one of the Top 50 pharmaceutical companies in India. It ranks amongst India’s few, fully integrated pharmaceutical firms with proficiencies across API, R&D, CRAM, Clinical Research and formulations, and exports to 96 countries. Centaur has four manufacturing facilities, two of which are USFDA approved. Centaur markets Sinarest, India's No.1 anti-cold brand since 1996. Centaur has won the AWACS- Brand of the Year Award for Sinarest consecutively for the last four years.
Centaur Pharmaceuticals’ state-of-the-art API Ambernath facility was audited by the USFDA and a 483 form was issued with one observation which was responded to, immediately. Centaur has now received a formal EIR (Establishment Inspection Report) from USFDA stating the facility is cGMP c... (more)
Prevalence of Chronic Kidney Disease in India is 17.2% and rising[1]
Dialysis is a painful and expensive process with scarcely available resources
This novel, US-patented, and clinically-tested product helps maintain healthy kidney functions
